CY1105254T1 - Θepαπεια του διαβητη με θειαζολιδινδιονη, εκκριταγωγο ινσουλινης και διγουανιδιο - Google Patents
Θepαπεια του διαβητη με θειαζολιδινδιονη, εκκριταγωγο ινσουλινης και διγουανιδιοInfo
- Publication number
- CY1105254T1 CY1105254T1 CY20051101486T CY051101486T CY1105254T1 CY 1105254 T1 CY1105254 T1 CY 1105254T1 CY 20051101486 T CY20051101486 T CY 20051101486T CY 051101486 T CY051101486 T CY 051101486T CY 1105254 T1 CY1105254 T1 CY 1105254T1
- Authority
- CY
- Cyprus
- Prior art keywords
- insulin
- secretago
- diguanidium
- thiazolidinedione
- diabetes
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 title 1
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 229940123464 Thiazolidinedione Drugs 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 abstract 1
- 229940123208 Biguanide Drugs 0.000 abstract 1
- 229940122199 Insulin secretagogue Drugs 0.000 abstract 1
- 229940122355 Insulin sensitizer Drugs 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9715295A GB9715295D0 (en) | 1997-07-18 | 1997-07-18 | Novel method of treatment |
| PCT/GB1998/002110 WO1999003477A1 (en) | 1997-07-18 | 1998-07-16 | Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1105254T1 true CY1105254T1 (el) | 2010-03-03 |
Family
ID=10816167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20051101486T CY1105254T1 (el) | 1997-07-18 | 2005-12-07 | Θepαπεια του διαβητη με θειαζολιδινδιονη, εκκριταγωγο ινσουλινης και διγουανιδιο |
Country Status (39)
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
| US6099862A (en) * | 1998-08-31 | 2000-08-08 | Andrx Corporation | Oral dosage form for the controlled release of a biguanide and sulfonylurea |
| EP1813273A1 (en) * | 1998-11-12 | 2007-08-01 | Smithkline Beecham Plc | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| SE9902918D0 (sv) * | 1999-08-13 | 1999-08-13 | Pharmacia & Upjohn Ab | Methods for identification of compounds stimulating insulin secretion |
| AU1403501A (en) * | 1999-11-16 | 2001-05-30 | Smithkline Beecham Plc | Novel composition and use |
| AR030920A1 (es) | 1999-11-16 | 2003-09-03 | Smithkline Beecham Plc | Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones |
| FR2812547B1 (fr) * | 2000-08-04 | 2002-10-31 | Lipha | Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete |
| ATE508738T1 (de) | 2001-01-12 | 2011-05-15 | Sun Pharma Advanced Res Co Ltd | System zur beabstandeten abgabe von arzneimitteln |
| ITFI20010126A1 (it) * | 2001-07-09 | 2003-01-09 | Molteni & C | Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide |
| EP1429747A4 (en) * | 2001-07-10 | 2005-01-05 | Kos Life Sciences Inc | CORE FORMULATION WITH PIOGLITAZONE HYDROCHLORIDE AND A BIGUANIDE |
| PL376577A1 (pl) | 2002-06-17 | 2006-01-09 | Themis Laboratories Private Limited | Wielowarstwowe tabletki zawierające tiazolidinedion i biguanidy oraz metody ich wytwarzania |
| KR101363679B1 (ko) * | 2002-09-20 | 2014-02-14 | 안드렉스 랩스 엘엘씨 | 약제학적 정제 |
| UA80991C2 (en) | 2002-10-07 | 2007-11-26 | Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes | |
| PL1677792T3 (pl) | 2003-10-31 | 2016-05-31 | Takeda Pharmaceuticals Co | Stały preparat zawierający pioglitazon, glimepiryd i ester polioksyetylenosorbitanu z kwasem tłuszczowym |
| MXPA05010977A (es) * | 2005-10-12 | 2007-04-11 | Abdala Leopoldo Espinosa | Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus. |
| KR100812538B1 (ko) * | 2006-10-23 | 2008-03-11 | 한올제약주식회사 | 약물 제어방출형 메트포르민-글리메피리드 복합제제 |
| CN101417130B (zh) * | 2007-10-22 | 2010-10-06 | 鲁南制药集团股份有限公司 | 一种治疗ⅱ型糖尿病及其并发症的药物组合物 |
| US11607441B2 (en) | 2017-10-20 | 2023-03-21 | Novmetapharma Co., Ltd. | Pharmaceutical composition for preventing or treating diabetes, containing zinc salt, cyclo-hispro and antidiabetic drug as active ingredients |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
| JPS5697277A (en) * | 1980-01-07 | 1981-08-05 | Takeda Chem Ind Ltd | Thiazolidine derivative |
| JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
| US4582839A (en) * | 1984-03-21 | 1986-04-15 | Takeda Chemical Industries, Ltd. | 2,4-thiazolidinediones |
| CN1003445B (zh) * | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物，其制备方法和用途 |
| JPH06779B2 (ja) * | 1985-06-10 | 1994-01-05 | 武田薬品工業株式会社 | チアゾリジオン誘導体およびそれを含んでなる医薬組成物 |
| US4812570A (en) * | 1986-07-24 | 1989-03-14 | Takeda Chemical Industries, Ltd. | Method for producing thiazolidinedione derivatives |
| US4791125A (en) * | 1987-12-02 | 1988-12-13 | Pfizer Inc. | Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents |
| WO1989008651A1 (en) * | 1988-03-08 | 1989-09-21 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
| FI904414A7 (fi) * | 1988-03-08 | 1990-09-07 | Pfizer | Tiatsolidiinidioni-hypoglykeemisesti vaikuttavat aineet |
| WO1991007107A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Oxazolidinedione hypoglycemic agents |
| JPH04210683A (ja) * | 1990-12-06 | 1992-07-31 | Terumo Corp | チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬 |
| ATE151634T1 (de) * | 1991-08-26 | 1997-05-15 | Upjohn Co | Flüssiges nahrungsmittel, das 3- guanidinopropionsäure enthält |
| US5917052A (en) * | 1994-09-28 | 1999-06-29 | Shaman Pharmaceuticals, Inc. | Hypoglycemic agent from cryptolepis |
| TW438587B (en) * | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| CZ299310B6 (cs) * | 1997-06-18 | 2008-06-18 | Smithkline Beecham Plc | Lécivo pro lécbu diabetes mellitus a stavu spojených s diabetes mellitus |
-
1997
- 1997-07-18 GB GB9715295A patent/GB9715295D0/en active Pending
-
1998
- 1998-07-15 DZ DZ980172A patent/DZ2562A1/xx active
- 1998-07-16 CN CN98807319A patent/CN1264303A/zh active Pending
- 1998-07-16 AR ARP980103481A patent/AR016349A1/es unknown
- 1998-07-16 NZ NZ501164A patent/NZ501164A/en unknown
- 1998-07-16 ID IDW20000075A patent/ID24211A/id unknown
- 1998-07-16 WO PCT/GB1998/002110 patent/WO1999003477A1/en active IP Right Grant
- 1998-07-16 AU AU84488/98A patent/AU8448898A/en not_active Abandoned
- 1998-07-16 ES ES98935127T patent/ES2251093T3/es not_active Expired - Lifetime
- 1998-07-16 EP EP98935127A patent/EP1001783B1/en not_active Expired - Lifetime
- 1998-07-16 HU HU0003629A patent/HUP0003629A3/hu unknown
- 1998-07-16 IL IL13404698A patent/IL134046A0/xx unknown
- 1998-07-16 KR KR1020007000512A patent/KR100671918B1/ko not_active Expired - Fee Related
- 1998-07-16 JP JP2000502776A patent/JP2001510159A/ja not_active Withdrawn
- 1998-07-16 DE DE69831808T patent/DE69831808T2/de not_active Expired - Fee Related
- 1998-07-16 CA CA002296653A patent/CA2296653C/en not_active Expired - Fee Related
- 1998-07-16 DK DK98935127T patent/DK1001783T3/da active
- 1998-07-16 AP APAP/P/2000/001733A patent/AP1352A/en active
- 1998-07-16 NZ NZ511608A patent/NZ511608A/xx unknown
- 1998-07-16 TR TR2000/00134T patent/TR200000134T2/xx unknown
- 1998-07-16 EA EA200000139A patent/EA003021B1/ru not_active IP Right Cessation
- 1998-07-16 MA MA25171A patent/MA24607A1/fr unknown
- 1998-07-16 BR BR9810445-4A patent/BR9810445A/pt not_active Application Discontinuation
- 1998-07-16 SK SK59-2000A patent/SK285484B6/sk not_active IP Right Cessation
- 1998-07-16 AT AT98935127T patent/ATE305790T1/de not_active IP Right Cessation
- 1998-07-16 SI SI9830804T patent/SI1001783T1/sl unknown
- 1998-07-16 PL PL338126A patent/PL197844B1/pl not_active IP Right Cessation
- 1998-07-16 PL PL378474A patent/PL198017B1/pl not_active IP Right Cessation
- 1998-07-16 PE PE1998000629A patent/PE99599A1/es not_active Application Discontinuation
- 1998-07-16 UA UA2000010261A patent/UA70303C2/uk unknown
- 1998-07-17 TW TW087111770A patent/TW505516B/zh active
- 1998-07-17 UY UY25102A patent/UY25102A1/es not_active IP Right Cessation
- 1998-07-17 CO CO98040747A patent/CO4940420A1/es unknown
- 1998-07-17 ZA ZA9806363A patent/ZA986363B/xx unknown
- 1998-07-17 MY MYPI98003288A patent/MY155219A/en unknown
- 1998-07-20 IN IN2087DE1998 patent/IN189275B/en unknown
- 1998-08-29 SA SA98190468A patent/SA98190468B1/ar unknown
-
2000
- 2000-01-17 NO NO20000228A patent/NO325727B1/no not_active IP Right Cessation
- 2000-01-18 OA OA1200000012A patent/OA11279A/en unknown
- 2000-02-07 BG BG104135A patent/BG64785B1/bg unknown
-
2005
- 2005-04-21 JP JP2005123562A patent/JP2005213273A/ja active Pending
- 2005-12-07 CY CY20051101486T patent/CY1105254T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1105254T1 (el) | Θepαπεια του διαβητη με θειαζολιδινδιονη, εκκριταγωγο ινσουλινης και διγουανιδιο | |
| CY1107643T1 (el) | Αντιμετωπιση του διαβητη με θειαζολιδινοδιονη και μετφορμινη | |
| DE69327309D1 (de) | Verwendung eines peptids | |
| ATE228849T1 (de) | Behandlung des typ ii-deabetes mellitus mit amylinagonisten | |
| ES2059121T3 (es) | Uso de agentes sensibilizantes de insulina para tratar la hipertension. | |
| CY1107745T1 (el) | Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουρια | |
| NO883306D0 (no) | Farmasoeytisk aktive konjugater med forbedret bindingsspesifisitet for kroppsvev. | |
| BR9810444A (pt) | Tratamento de diabete com rosiglitazona e insulina | |
| BR9810292A (pt) | Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e inibidor de alfa-glicosidase | |
| BR9810142A (pt) | Tratamento de diabete com tiazolidinadiona e sulfonil-uréia | |
| BR9810186A (pt) | Tratamento de diabete com tiazolidinadiona e inibidor de alfa-glicosidade | |
| TR200101336T2 (tr) | Bir-beta-agonisti ile başka bir antidiyabetik madde içeren kombinasyonlar | |
| PT95118A (pt) | Metodo para o tratamento de dependencias quimicas utilizando sertralina | |
| TR200000957T2 (tr) | Hiperglisemi tedavisinde tiazolidinedion kullanımı | |
| UY25801A1 (es) | Procedimiento para preparar composiciones para el tratamiento de diabetes. | |
| ECSP982535A (es) | Nuevo metodo de tratamiento (i) | |
| ECSP982591A (es) | Nuevo metodo de tratamiento iv | |
| ECSP982593A (es) | Nuevo metodo de tratamiento vi | |
| ECSP982592A (es) | Nuevo metodo de tratamiento v | |
| ECSP982542A (es) | Nuevo metodo de tratamiento iii | |
| ECSP982541A (es) | Nuevo metodo de tratamiento ii | |
| TR200000958T2 (tr) | Hiperglisemi tedavisinde tiazolidinedion kullanımı. | |
| TH21154B (th) | กรรมวิธีในการรักษาโรคเบาหวานด้วยไธอะโซลิดีนไดโอนและเมทฟอร์มิน |